SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is seeing intense community speculation as investors position themselves ahead of the upcoming earnings release, with discussions centering on the company's progress under new leadership and potential for a breakout. Enthusiastic retail participants are debating the impact of strategic housing market initiatives and tracking sentiment against bearish short-interest concerns.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending due to heightened community anticipation ahead of its upcoming earnings report, with investors weighing concerns over North American user growth against a growing narrative of improved operational efficiency and potential AI-driven monetization. Discussions are polarized, as some shareholders focus on long-term turnaround potential through cost-cutting and hardware innovation, while others remain critical of management and historical performance.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing heightened investor debate as the stock faces downward pressure near 52-week lows, fueling community speculation about institutional manipulation versus legitimate concerns over competitive headwinds and integration noise. Investors are closely monitoring the upcoming earnings announcement for signs of a turnaround, with bullish sentiment anchored by long-term growth prospects, strong brand loyalty, and the potential for a post-earnings recovery.

Axe Compute, Inc. engages in the provision of graphics processing unit compute capacity for artificial intelligence and other complex computing workloads. It operates through the following segments: Compute Services and Treasury Management segment, and Drug Discovery Services segment. The Compute Services and Treasury Management segment provides services that include access to GPU compute capacity and manage the ATH Treasury Strategy. The Drug Discovery Services segment provides services that include the application of AI, creation of specific 3D culture models used in drug development. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Pittsburgh, PA.

Axe Compute Inc.

Axe Compute Inc. Common Stock

Axe Compute Inc. is trending following the announcement of a significant multi-year enterprise contract to deploy Nvidia hardware, fueling community speculation about the company's valuation and revenue potential. While some investors are bullish on the AI infrastructure narrative and recent insider activity, others are actively debating potential dilution risks and the stock's high volatility.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is seeing intense investor focus as community members anticipate near-term trial enrollment completion and regulatory progress toward a BLA submission for its NXC-201 therapy. The conversation is currently dominated by discussions around the potential for a strategic buyout or short squeeze, fueled by the stock's tight float, significant institutional accumulation, and the high-conviction clinical data in AL amyloidosis.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is currently in the spotlight as investors weigh its aggressive expansion into the data center CPU market against concerns over supply constraints and high valuation. While the community remains divided over the sustainability of its rapid growth, there is significant active discussion regarding its shift toward becoming a cornerstone of AI infrastructure.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Adma Biologics is currently the center of intense debate following a short-seller report that triggered a sharp selloff, despite the company's aggressive rebuttal and a massive share buyback program. Investors are actively split between those who view the current price as a generational buying opportunity based on strong ASCENIV demand and pending label expansions, and those who remain skeptical due to the withdrawal of long-term guidance and ongoing competitive headwinds.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Root Inc. is trending as investors weigh strong profitability gains against slowing policy growth and reduced marketing spend. Community sentiment is deeply polarized, with bulls highlighting the potential of the Carvana partnership and share buyback program, while skeptics point to insider selling and concerns over the long-term sustainability of the current growth model.

Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Ernexa Therapeutics Inc.

Ernexa Therapeutics is trending as the community debates the validity of recent preclinical data showing complete tumor clearance in ovarian cancer models against concerns regarding share dilution and historical reverse splits. Investors are actively split between those betting on the company's clinical pipeline and institutional partnerships as a catalyst for a short squeeze, and those warning of a potential 'dilution trap' following the latest volatility.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

Rage Guy ($RAGE) is rallying community support as a tokenized tribute to internet history, with users actively engaging in meme creation contests and building on original domains. Supporters are highlighting the project as a 'conviction play' while coordinating social media campaigns to gain broader visibility for this Solana-based meme asset.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Recommendation of "Hold" by Brokerages

OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) has earned an average recommendation of 'Hold' from the six brokerages that are covering the company, Marketbeat reports. One investment analyst has...

HC Wainwright Boosts Earnings Estimates for OPKO Health

OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Analysts at HC Wainwright lifted their FY2026 earnings estimates for shares of OPKO Health in a research note issued to investors on Wednesday, April...

Q1 Earnings Estimate for OPKO Health Issued By HC Wainwright

OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Analysts at HC Wainwright issued their Q1 2027 earnings per share (EPS) estimates for shares of OPKO Health in a research report issued to clients and investors on Wednesday, April 29th. HC Wainwright analyst Y. Chen expects that the biotechnology compa...

OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y

OPK's Q1 earnings match estimates as pharma product sales rose, but revenue slides 25.7% after a smaller BioReference diagnostics base.

OPKO Health (NASDAQ:OPK) Hits New 1-Year Low  - Should You Sell?

OPKO Health (NASDAQ:OPK) Reaches New 1-Year Low - What's Next...

OPKO Health Q1 2026 Earnings Call: Complete Transcript

OPKO Health Q1 Earnings Call Highlights

OPKO Health (NASDAQ:OPK) reported first-quarter 2026 results and highlighted continued progress across its ModeX Therapeutics pipeline, along with ongoing restructuring in diagnostics and growth in international pharmaceutical operations.

ModeX pipeline expands clinical activity and partnerships
Ch...

OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates

OPKO Health (OPK) delivered earnings and revenue surprises of -2.94% and -4.87%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

OPKO Health (OPK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for OPKO Health (OPK) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

OPKO Health (NASDAQ:OPK) Announces Quarterly Earnings Results, Hits Estimates

OPKO Health (NASDAQ:OPK - Get Free Report) issued its quarterly earnings data on Tuesday. The biotechnology company reported ($0.07) earnings per share (EPS) for the quarter, hitting analysts...

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment manages the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Opko Health Inc

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

OPK
Opko Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest OPK News

OPKOpko Health Inc